Stay updated with breaking news from Dbv Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Stephen Nakrosis DBV Technologies said it received requested feedback from the U.S. Food and Drug Administration for a pair of supplemental safety studies...
DBVT's Q3 2023 Earnings Highlighted by FDA Feedback and Financial Performance
StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research note issued to investors on Saturday. The firm issued a sell rating on the stock. A number of other analysts have also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $10.00 price target […]
StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research note published on Saturday. The firm issued a sell rating on the stock. Several other research analysts have also commented on DBVT. HC Wainwright reaffirmed a buy rating and issued a $10.00 price target on shares of DBV Technologies in […]
DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report) Director Timothy E. Morris acquired 12,000 shares of DBV Technologies stock in a transaction dated Friday, August 25th. The shares were bought at an average cost of $1.52 per share, for a total transaction of $18,240.00. Following the completion of the purchase, the director now directly owns […]